The dose and timing of antimicrobial agents given for surgical wound prophylaxis should be based on the concentration-time profile of the drug in tissue at the site of contamination. However, concentrations of antimicrobial agents in surgical wounds are difficult to determine accurately. Since a surgical wound is a unique extravascular compartment with increased vascular permeability and a high surface area/volume ratio, antibiotic concentrations in sera and surgical wounds should be similar. To test this hypothesis, the pharmacokinetics of single intravenous doses of cefazolin (40 mg/kg) and gentamicin (4 mg/kg) in sera and surgical wounds in a clinically relevant surgical model using dogs were compared. Drug concentrations were determined in interstitial fluid in muscle biopsies taken randomly from wound surfaces and serial wound fluid samples collected after the incisions were closed. Protein binding of cefazolin and gentamicin in sera and wound fluids was low (c29 + 9%) in this canine model. Cefazolin and gentamicin equilibrated rapidly (s30 min) between serum and the surgical wound, and concentrations in the two sites declined in parallel. Values for the area under the concentration-time curve, mean residence time, and terminal half-life in serum and the surgical site for each drug were similar. Cefazolin concentrations in serum underestimated the time during which concentrations in surgical wounds exceeded the susceptibility breakpoint MIC for important pathogens by an average of 58 min (range, 26 to 109 min; P = 0.036); for gentamicin, the underestimation averaged 30 min (range, 10 to 60 min; P = 0.036). These data support the concept that the concentration-time profiles of antimicrobial agents in serum may prove valuable clinically as guides to determining the dose and timing of antibiotic administration necessary for effective antimicrobial prophylaxis in surgery. Further studies are needed to determine the surgical wound pharmacokinetics of highly protein-bound antibiotics.
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For effective antimicrobial prophylaxis, antibiotics must be present in tissue at the surgical site throughout the operation in concentrations sufficient to prevent growth of contaminating pathogenic microorganisms (11) . Clinical trials in surgical patients have shown that prophylaxis can fail if the antibiotic dose is too low or the half-life in tissue is too short (5, 10, 14) . The dose and timing of antibiotic administration for prophylaxis should be based on the concentration-time profile of the drug in the surgical wound. Unfortunately, concentrations of antibiotics at surgical sites are difficult to determine accurately. Levels Cefazolin rapidly equilibrated between serum and the surgical wound; the concentrations at the surgical wound paralleled those in serum; i.e., both declined at a biexponential rate (Fig. 1) . The rate of gentamicin transfer from serum to the surgical wound was more variable; in three of six animals, a slight delay in equilibration between the concentrations in sera and surgical wounds was observed, but in all animals the difference between the concentrations at the two sites became negligible within 30 min after dosing (Fig. 2) .
Comparison the AUC of the drug at the surgical wound with that of the drug in serum showed that the extent of delivery of both agents was excellent; the mean levels of both drugs at surgical wounds were comparable to or slightly higher than those in sera (Tables 2 and 3 ). The difference between surgical wound and serum AUCs was statistically significant for gentamicin but not for cefazolin.
The MRTs of gentamicin and cefazolin at surgical wounds were significantly longer than those in sera (Tables 2 and 3 ). This appeared to be due primarily to a slower rate of removal from surgical wounds. A small albeit detectable delay in gentamicin equilibration between sera and surgical wounds may also have contributed to differences between serum and surgical wound MRTs. The mean tl2,, for cefazolin in surgical wounds was 104 min compared with 66 min in sera (P = 0.036). For gentamicin, the mean t4/2, values for surgical wounds and sera were 92 and 64 min, respectively (P = 0.059).
A clinically relevant parameter for determining antimicrobial agent dosage for surgical prophylaxis is the time during which concentrations at a surgical wound exceed the MIC for potential pathogens. Cefazolin concentrations in sera underestimated the time during which inhibitory levels were maintained at surgical wounds by an average of 58 min (range, 26 to 109 min; P = 0.036); for gentamicin, the underestimation averaged 30 min (range, 10 to 60 min; P = 0.036) ( Table 4) . DISCUSSION A surgical wound is a unique extravascular space. The trauma of surgery is a severe injury which causes an immediate and sustained increase in capillary permeability in tissue at the surgical site (16) . Closure of the wound creates a compartment with a high surface area/volume (SAIV) ratio.
The wound fluid that fills this compartment is a serosanguineous exudate derived from blood plasma as part of the acute inflammation caused by surgery (16) . We propose that this fluid, along with the interstitial fluid in tissue at the perimeter of the wound, is the site of antibiotic-microorganism interaction and the location of postoperative wound infection. The concentration of antibiotics in surgical wound extracellular fluid is a critical factor in determining the incidence of wound infection after surgery. The canine model developed for this study was effective and clinically relevant for comparison of antibiotic concentrations in serum and surgical site extracellular fluid in an actual surgical wound during the decisive period when antimicrobial prophylaxis is capable of suppressing the growth of contaminating microorganisms.
Our data show that cefazolin and gentamicin equilibrate rapidly between serum and the extracellular fluid in a surgical wound. Our findings confirm the results of previous studies using artificially created models with a high SA/V ratio (i.e., filter paper disk, cotton thread, and an in vitro kinetic model) which noted that drug concentrations in these fluid spaces tend to parallel changes in serum (3, 6, (17) (18) (19) . In contrast, drug concentrations in chamber models with a low SA/V ratio (i.e., blister fluid, tissue cage), which are not representative of a surgical wound, have delayed equilibrium, lower peak levels, and prolonged concentrations in comparison with serum (1, 3, 4, 6, 20) .
The low protein binding of cefazolin and gentamicin in serum and wound fluid in this canine model may be a factor in the high extent of antibiotic penetration and rapid equili- We conclude that low protein-bound antibiotic concentrations in serum parallel the levels in a surgical wound and levels in serum slightly underestimate the time during which effective levels are maintained at the surgical site. Therefore, the concentration-time profile of antibiotic levels in serum may prove valuable clinically as a guide to determining the dose and timing of antibiotic administration necessary for effective surgical antimicrobial prophylaxis. Further studies are needed to determine the surgical site pharmacokinetics of highly protein-bound antibiotics.
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